Literature DB >> 16412790

CD4+CD25+ regulatory T cells and graft-versus-host disease.

Petra Hoffmann1, Matthias Edinger.   

Abstract

Peripheral suppression of autoreactive T cells by specialized T-cell populations is one of several mechanisms ensuring self-tolerance within the adaptive immune system. Thymus-derived CD4+CD25+ T cells expressing the transcriptional repressor FOXP3 mediate such immunoregulatory functions and are pivotal for the prevention of autoimmunity. As peripheral tolerance induction is a prerequisite for successful treatment outcome after allogeneic hematopoietic stem cell transplantation (HSCT), the role of CD4+CD25+ T cells in transplantation models and clinical trials is now under investigation in many laboratories. Here we summarize recent results regarding protection from graft-versus-host disease (GVHD) by adoptively transferred CD4+CD25+ T cells in mice and discuss early findings from clinical studies in HSCT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412790     DOI: 10.1053/j.seminhematol.2005.09.006

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  16 in total

1.  Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.

Authors:  Huahua Fan; Jie Yang; Jun Hao; Yana Ren; Liang Chen; Guiping Li; Rufeng Xie; Yiming Yang; Feng Gao; Mingyao Liu
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 2.  Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

Authors:  James M Coghill; Stefanie Sarantopoulos; Timothy P Moran; William J Murphy; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

Review 3.  Concise review: hitting the right spot with mesenchymal stromal cells.

Authors:  Jakub Tolar; Katarina Le Blanc; Armand Keating; Bruce R Blazar
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

4.  Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures.

Authors:  Dat Q Tran; John Andersson; Donna Hardwick; Lolita Bebris; Gabor G Illei; Ethan M Shevach
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

5.  Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.

Authors:  Michael H Albert; Xue-Zhong Yu; Thomas Magg
Journal:  Clin Immunol       Date:  2008-09-25       Impact factor: 3.969

6.  Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.

Authors:  Giorgia Serafini; Marco Andreani; Manuela Testi; MariaRosa Battarra; Andrea Bontadini; Eika Biral; Katharina Fleischhauer; Sarah Marktel; Guido Lucarelli; Maria Grazia Roncarolo; Rosa Bacchetta
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

7.  Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.

Authors:  Emmanuel Zorn; Mehrdad Mohseni; Haesook Kim; Fabrice Porcheray; Allison Lynch; Roberto Bellucci; Christine Canning; Edwin P Alyea; Robert J Soiffer; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

8.  Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor.

Authors:  Z Shamim; S Spellman; M Haagenson; T Wang; S J Lee; L P Ryder; K Müller
Journal:  Scand J Immunol       Date:  2013-08       Impact factor: 3.487

9.  Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects.

Authors:  Takashi Miyake; Naoki Hosaka; Wenhao Cui; Teruhisa Nishida; Takashi Takaki; Muneo Inaba; Yasuo Kamiyama; Susumu Ikehara
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

10.  Harvesting, processing and inventory management of peripheral blood stem cells.

Authors:  Aleksandar Mijovic; Derwood Pamphilon
Journal:  Asian J Transfus Sci       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.